Recent News

• 12.05.2025 - CORRESP - Correspondence
• 12.05.2025 - UPLOAD - SEC-generated letter
• 12.01.2025 - 8-K - Current report
• 12.01.2025 - Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
• 11.28.2025 - 4 - Statement of changes in beneficial ownership of securities
• 11.26.2025 - 4 - Statement of changes in beneficial ownership of securities
• 11.14.2025 - 8-K - Current report
• 11.14.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
• 10.30.2025 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership

Recent Filings

• 12.01.2025 - EX-99.1 EX-99.1
• 12.01.2025 - 8-K Current report
• 11.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - EX-99.1 EX-99.1
• 11.14.2025 - 8-K Current report